
Founded in 2014, MAGENTIQ EYE offers a groundbreaking AI-aided colonoscopy solution, MAGENTIQ-COLO™, which enhances diagnostic capabilities in gastroenterology. With over 65 million frames processed and validation from extensive clinical studies, the product significantly improves adenoma detection rates, thereby reducing colorectal cancer occurrences. The company has received worldwide recognition and is setting new standards in colonoscopy, with a fast-growing client base and a commitment to continuous innovation in the field.

Founded in 2014, MAGENTIQ EYE offers a groundbreaking AI-aided colonoscopy solution, MAGENTIQ-COLO™, which enhances diagnostic capabilities in gastroenterology. With over 65 million frames processed and validation from extensive clinical studies, the product significantly improves adenoma detection rates, thereby reducing colorectal cancer occurrences. The company has received worldwide recognition and is setting new standards in colonoscopy, with a fast-growing client base and a commitment to continuous innovation in the field.